A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia
Clinical trial NCT07278830 · COMPLETED
Trial details
- NCT number
- NCT07278830
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2024-05-24
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.